Dr Christine Rousseau

Christine is a senior programme officer at the Bill & Melinda Gates Foundation. She currently leads the foundation's HIV diagnostics initiative and contributes to cross-cutting diagnostics discovery. 

Prior to this work, Christine was an academic scientist. She served as a faculty member at the University of Washington Health Services R&D department and the Veterans Administration Hepatitis C Resource Centre, where she identified racial inequities in treatment for hepatitis C infection. Her most recent position at the University of Washington involved, in part, the population-level modeling of viral evolution in response to host genetic factors, leading to the identification of viral variants predicted to be susceptible or resistant to particular host immune responses, serving to inform vaccine design.

Christine has a doctorate in Genetics from the University of California at Berkeley where she evaluated host genetic and viral factors influencing perinatal HIV transmission among a cohort of women in Harlem New York. She completed a postdoctoral fellowship at the Fred Hutchinson Cancer Research Center participating in a project based in Nairobi, Kenya where she identified the importance of cell-mediated transmission in breast feeding transmission of HIV. 

In parallel to her academic work, Christine founded a non-profit organisation (Sustainable Sciences Institute), which provides scientific capacity building in developing countries worldwide through training programs, small grants, scientific networking and material aid.

Christine is the Foundation's Project Officer for the Diagnostics Modelling Consortium.

Research area(s):